Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey N Bryan

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
American Journal of Veterinary Research|September 24, 2020
Biochemical, functional, and histopathologic characterization of lomustine-induced liver injury in dogsAndrea M Dedeaux, Brian K Flesner, Jennifer M Reinhart, et al.
Nature Communications|May 12, 2021
Portable bioluminescent platform for in vivo monitoring of biological processes in non-transgenic animalsAleksey Yevtodiyenko, Arkadiy Bazhin, Pavlo Khodakivskyi, et al.
BMC Genetics|November 17, 2009
Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphomaJeffrey N Bryan, Mohamed Jabbes, Linda M Berent, et al.
Molecular Pharmaceutics|May 31, 2022
Pretargeted PET of Osteodestructive Lesions in DogsCharles A Maitz, Samantha Delaney, Brendon E Cook, et al.
Experimental Eye Research|September 18, 2016
Intravitreal implantation of TPP1-transduced stem cells delays retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosisChristopher J Tracy, Rebecca E H Whiting, Jacqueline W Pearce, et al.
Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association|July 11, 2023
Phase I evaluation of CycloSam<sup>®</sup> (Sm-153-DOTMP) bone seeking radiopharmaceutical in dogs with spontaneous appendicular osteosarcomaKim A Selting, Jaime Simon, Jim C Lattimer, et al.
Bioconjugate Chemistry|November 8, 2011
Comparison of pretargeted and conventional CC49 radioimmunotherapy using 149Pm, 166Ho, and 177LuHuma Mohsin, Fang Jia, Jeffrey N Bryan, et al.
Journal of Pharmaceutical Sciences|May 9, 2016
Hyaluronan-Lysine Cisplatin Drug Carrier for Treatment of Localized Cancers: Pharmacokinetics, Tolerability, and Efficacy in Rodents and CaninesTi Zhang, Shuang Cai, Chad Groer, et al.
International Journal of Nanomedicine|November 8, 2014
Gum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancerSandra M Axiak-Bechtel, Anandhi Upendran, Jimmy C Lattimer, et al.
Journal of Veterinary Internal Medicine|July 11, 2020
Autologous cancer cell vaccination, adoptive T-cell transfer, and interleukin-2 administration results in long-term survival for companion dogs with osteosarcomaBrian K Flesner, Gary W Wood, Pamela Gayheart-Walsten, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
American Journal of Veterinary Research|September 24, 2020
Biochemical, functional, and histopathologic characterization of lomustine-induced liver injury in dogsAndrea M Dedeaux, Brian K Flesner, Jennifer M Reinhart, et al.
Nature Communications|May 12, 2021
Portable bioluminescent platform for in vivo monitoring of biological processes in non-transgenic animalsAleksey Yevtodiyenko, Arkadiy Bazhin, Pavlo Khodakivskyi, et al.
BMC Genetics|November 17, 2009
Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphomaJeffrey N Bryan, Mohamed Jabbes, Linda M Berent, et al.
Molecular Pharmaceutics|May 31, 2022
Pretargeted PET of Osteodestructive Lesions in DogsCharles A Maitz, Samantha Delaney, Brendon E Cook, et al.
Experimental Eye Research|September 18, 2016
Intravitreal implantation of TPP1-transduced stem cells delays retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosisChristopher J Tracy, Rebecca E H Whiting, Jacqueline W Pearce, et al.
Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association|July 11, 2023
Phase I evaluation of CycloSam<sup>®</sup> (Sm-153-DOTMP) bone seeking radiopharmaceutical in dogs with spontaneous appendicular osteosarcomaKim A Selting, Jaime Simon, Jim C Lattimer, et al.
Bioconjugate Chemistry|November 8, 2011
Comparison of pretargeted and conventional CC49 radioimmunotherapy using 149Pm, 166Ho, and 177LuHuma Mohsin, Fang Jia, Jeffrey N Bryan, et al.
Journal of Pharmaceutical Sciences|May 9, 2016
Hyaluronan-Lysine Cisplatin Drug Carrier for Treatment of Localized Cancers: Pharmacokinetics, Tolerability, and Efficacy in Rodents and CaninesTi Zhang, Shuang Cai, Chad Groer, et al.
International Journal of Nanomedicine|November 8, 2014
Gum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancerSandra M Axiak-Bechtel, Anandhi Upendran, Jimmy C Lattimer, et al.
Journal of Veterinary Internal Medicine|July 11, 2020
Autologous cancer cell vaccination, adoptive T-cell transfer, and interleukin-2 administration results in long-term survival for companion dogs with osteosarcomaBrian K Flesner, Gary W Wood, Pamela Gayheart-Walsten, et al.
Pageof 9